Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on July 30, 2009

Stroke. 2009
Published online before print July 30, 2009, doi: 10.1161/STROKEAHA.109.559070
A more recent version of this article appeared on September 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/9/3163    most recent
STROKEAHA.109.559070v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Donnan, G. A.
Right arrow Articles by Davis, S. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Donnan, G. A.
Right arrow Articles by Davis, S. M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stroke
Related Collections
Right arrow ACE/Angiotension receptors

Submitted on June 30, 2009
Accepted on June 30, 2009

Angiotensin Receptor Blockers and Stroke Therapy. It Is All About the Blood Pressure

Geoffrey A. Donnan MD, FRACP and Stephen M. Davis MD, FRACP*

From the National Stroke Research Institute (G.A.D.), Melbourne, Australia; and Royal Melbourne Hospital (S.M.D.), Parkville, Victoria, Australia.

* To whom correspondence should be addressed. E-mail: stephen.davis{at}mh.org.au.


Key words: controversy • prevention • risk factors